CD4 and neoplasm: Compared to the NQO1 group, the combined Plerixafor group indicated significantly increased infiltration of CD3+ T cells in the tumor tissue (Figure S10C, Supporting Information), while the infiltration of Treg cells (FOXP3+CD4+ and FOXP3+CD25+CD4+) was significantly reduced (Figure 8D).